Markets市場

Pomerantz Law Firm Files Class Action Against Immutep Limited as IMMP Investors Face Upcoming Deadlines

New York-based Pomerantz LLP has filed a class action lawsuit against Immutep Limited, the Nasdaq-listed biopharmaceutical company trading under the ticker IMMP, the law firm announced on July 2,

By Mara Whitfield·July 3, 2026·二〇二六年七月三日·2 min read

Source · 來源

prnewswire.com

Share · 分享

X in f w

← Back to the News Desk Filed · Markets

Related Dispatches

相關報導

News Desk →

Elsewhere on the Desk

All Dispatches →

Regulatory

Axe Compute signs more than $3 billion in 2026 contracts as Q2 revenue reaches $3.2 million

August 17, 2026 · 2 min

Crypto加密

Chainalysis sues US government over $95M ICE contract awarded to TRM Labs

August 17, 2026 · 2 min

Regulatory

Carvana swaps distress-era debt for $1.66 billion term loan B, targeting 2033 maturity

August 17, 2026 · 2 min

Macro

Philippine central bank flags stronger second-round inflation effects

August 17, 2026 · 2 min

Pomerantz Law Firm Files Class Action Against Immutep Limited as IMMP Investors Face Upcoming Deadlines

Related Dispatches

The four stocks Wall Street fears most are also its best performers

3G Capital Partners exits Amazon and opens Intel position in second-quarter filings

Army awards Boeing $636 million contract for Apache helicopter support

Elsewhere on the Desk

Axe Compute signs more than $3 billion in 2026 contracts as Q2 revenue reaches $3.2 million

Chainalysis sues US government over $95M ICE contract awarded to TRM Labs

Carvana swaps distress-era debt for $1.66 billion term loan B, targeting 2033 maturity

Philippine central bank flags stronger second-round inflation effects